Cash conversion efficiency is severely strained, as demonstrated by the 2025Q3 period where $3.3 million in net income resulted in a negative $3.7 million operating cash flow.
| Cash from Operations | -6.21M | -1.01M | -83.2K |
| Operating CF Margin % | - | -8.93% | - |
| Operating CF Growth % | -3127.63% | -1117.5% | - |
| Net Income | 5.44M | 4M | -308.79K |
| Depreciation & Amortization | 331.06K | 194.6K | 0 |
| Stock-Based Compensation | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 |
| Other Non-Cash Items | -16.79M | -43.01M | 257.95K |
| Working Capital Changes | 4.81M | 37.8M | -32.36K |
| Change in Receivables | 991.38K | -20.79K | 0 |
| Change in Inventory | 170.63K | -1.39M | 0 |
| Change in Payables | -110.53K | 594.21K | 0 |
| Cash from Investing | -855.16K | -226.43K | -69M |
| Capital Expenditures | -514.09K | -1.81K | 0 |
| CapEx % of Revenue | 3.67% | 0.02% | - |
| Acquisitions | 0 | - | - |
| Investments | 140.46K | 72.75M | 69M |
| Other Investing | 27.17K | -224.62K | 0 |
| Cash from Financing | 1.74M | 582.87K | 69.74M |
| Debt Issued (Net) | 0 | - | - |
| Equity Issued (Net) | 0 | -141.91K | 70.75M |
| Dividends Paid | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 |
| Other Financing | 1.02M | 0 | 0 |
| Net Change in Cash | 37.2M | -656.52K | 656.98K |
| Free Cash Flow | 14.08M | 42.06M | -83.2K |
| FCF Margin % | 100.62% | 370.71% | - |
| FCF Growth % | - | 50657.69% | - |
| FCF per Share | 0.30 | 0.82 | -0.01 |
| FCF Conversion (FCF/Net Income) | 2.59x | -0.25x | 0.27x |
| Interest Paid | 0 | 0 | 0 |
| Taxes Paid | 85.53K | 108.72K | 0 |
Extreme Liquidity and Reporting Discrepancies
According to the provided financial data, the company's net income frequently decouples from operating cash flow, as evidenced by the 2025Q3 period where $3.3 million in reported net income resulted in a negative $3.7 million operating cash flow, signaling significant concerns regarding the quality of earnings.
The persistent divergence between accounting profits and actual cash generation suggests that reported income may be heavily influenced by non-cash accruals or aggressive revenue recognition policies. Investors should monitor whether these discrepancies represent timing differences in collections or a fundamental inability to convert high-margin sales into tangible liquidity.
As reported in recent financial statements, the company's free cash flow trajectory is highly erratic, swinging from a positive $22.3 million in 2024Q3 to a negative $4.1 million in 2025Q3, which highlights the instability of the firm's underlying cash-generating capacity across different reporting periods.
This extreme volatility in free cash flow suggests that the business model is susceptible to lumpy, project-based revenue cycles that fail to provide a reliable foundation for operational sustainability. The inability to maintain positive cash flow during periods of reported profitability warrants further investigation into the company's working capital management.
Based on the reported figures, working capital fluctuations appear to be the primary driver of cash flow instability, with a massive $12.6 million outflow in 2025Q3 alone, indicating that the company struggles to efficiently manage its receivables and payables cycle in alignment with revenue recognition.
The significant negative working capital changes suggest that the company may be extending aggressive credit terms to customers or facing delays in cash collection that severely constrain its operational liquidity. Such patterns often indicate that the company is financing its growth through the depletion of cash reserves rather than organic operational efficiency.
As indicated by the financial data, the company maintains a low capital intensity, with CAPEX as a percentage of revenue peaking at only 6.2% in 2025Q3, suggesting that the business model does not require heavy investment in physical assets to support its current operational scale.
While the low capital expenditure requirements appear to support a capital-light model, the lack of investment in infrastructure may limit the company's ability to scale its biotech-infused food production effectively. Analysts should consider whether this minimal spending reflects a strategic choice or a lack of available capital for necessary R&D and asset maintenance.
Quick answers to the most common questions about buying UCFIW stock.
CN Healthy Food Tech Group Corp. (UCFIW) generated $-1.0M in net cash from operating activities in 2024. This reflects the cash generated directly from core business operations.
CN Healthy Food Tech Group Corp. (UCFIW) generated $42.1M in free cash flow in 2024. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
CN Healthy Food Tech Group Corp. (UCFIW) spent $0.0M on capital expenditures in 2024. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.